Trending...
- Massachusetts: Baker-Polito Administration Launches COVID-19 Vaccine CDC Pharmacy Partnership - Phase 1, Expands Vaccine Locations & Names Fenway Park as Mass Vaccination Site
- Boston: A message from Commissioner McCosh: Inauguration event accessibility
- The Atlas Group adds Corbin Raines to their list of professional property managers
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced that the Company will present at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 at 10:50 a.m. ET.
A live webcast of the presentation can be accessed on the investor page of Sage's website at investor.sagerx.com. A replay of the webcast will also be archived for up to 30 days on Sage's website following the conference.
More on Boston Chron
About Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health, and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner. For more information, please visit www.sagerx.com.
A live webcast of the presentation can be accessed on the investor page of Sage's website at investor.sagerx.com. A replay of the webcast will also be archived for up to 30 days on Sage's website following the conference.
More on Boston Chron
- Congressional Medal of Honor Society will host 2021 convention in Boston
- Boston: Update on the Ronan Park Well
- Avery Design Announces CXL™ 2.0 VIP
- Nova Biomedical FLEX2 Cell Culture Analyzer Adds Sample Retain Capability
- Kaizen Finance Launches Staking to Foster the Widespread Adoption of DeFi
About Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health, and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner. For more information, please visit www.sagerx.com.
Filed Under: Business
0 Comments
Latest on Boston Chron
- Haemonetics Welcomes New FDA Guidance on Viscoelastic Testing During COVID-19 Pandemic
- Massachusetts: Baker- Polito Administration Expands Vaccine Access to All Eligible Residents in Phase One Effective Immediately
- China Refuses to Accept Service of Berman Law Group's Coronavirus Class Action Complaint
- Love & Sip Valentine Brunch with Celebrity The Comedian, Tomea, Grammy Saxophonist Jason Davis, Gospel Contemporary Duo, Only God Ministries
- Massachusetts: Baker-Polito Administration Awards Another $37 Million in Grants to 638 Businesses, Extends Capacity Limits and Lifts Early Closing Requirement for Businesses
- Phio Pharmaceuticals Announces $14.0 Million Private Placement Priced At-the-Market
- Wanderful Partners with Intrepid Travel to Launch Women and Allies Cruise in Antarctica
- Rustic Deco Launches B2B Wholesale Furniture Website
- Jenzabar Makes Senior Management Additions to its Business Development and Customer Operations Teams
- Hybrid Electric Vehicles: A Stay of Execution for NiMH Batteries, Explores IDTechEx
- Technological Innovation Required to Fill Gap in Indoor Navigation for Blind, Finds Strategy Analytics
- Massachusetts: Governor Baker Appoints Jamey Tesler Acting DOT Secretary Following MassDOT Secretary Stephanie Pollack's Appointment to the Federal Highway Administration
- IOTech names Gavin Hunter as VP of global marketing
- FundCount Named Best Hedge Fund System in the Bobsguide Awards
- Introducing BIAMI.IO Apps Framework
- Pro Golfer Kamaiu Johnson Joins Cambridge Mobile Telematics as Brand Ambassador
- Empirix Helps CEHE Confidently Migrate to Five9 Cloud-Based Contact Center Software USA - English USA - English
- Northway Biotech Opens New Biopharmaceutical Manufacturing Facility in Greater Boston Area
- Manulife Investment Management announces new managing director of institutional distribution, southeast region
- Boston: Meet some of this year's Opportunity Fund grantees